Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000454518 | SCV000538356 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 47% of total chromosomes in ExAC |
Gene |
RCV000837595 | SCV000979451 | benign | not provided | 2018-06-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001554113 | SCV001775286 | benign | Farber lipogranulomatosis | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554114 | SCV001775287 | benign | Spinal muscular atrophy-progressive myoclonic epilepsy syndrome | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000837595 | SCV005265990 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000454518 | SCV001919366 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000454518 | SCV001963014 | benign | not specified | no assertion criteria provided | clinical testing |